Management Board

Jakub Baran graduated from the Wroclaw University of Technology in 1995 with a Master of Science in Electronics. He began his career at Hewlett-Packard, where he held various positions. In 2003, he moved to IBM as sales manager for the telecommunications market. In 2005, he joined the board of PBKM, a company he was instrumental in founding. At PBKM, he was initially responsible for sales, finance and business development. He was appointed CEO in 2009 and successfully took the company public in 2015. Under his leadership, PBKM became the number 1 in Europe in stem cell banking for families. Jakub Baran has extensive experience in international expansion, M&A, strategy development and corporate management. Jakub Baran has been CEO of Vita 34 AG since 22 March 2022.

Thomas Pfaadt trained as a banker and studied business administration at Goethe University Frankfurt am Main and the University of Southampton. He began his career in M&A and corporate finance at PricewaterhouseCoopers and DZ Bank. He then took on management roles at two leading German companies in the healthcare sector, Asklepios Kliniken and MEDIAN Kliniken. In 2018, he became CFO and Managing Director at c-LEcta GmbH, a biotechnology company for enzyme products. Thomas Pfaadt has been CFO of Vita 34 AG since 1 August 2024.

Tomasz Baran received his doctorate from the Medical University in Lublin, Poland, in 1997. He has held various positions in the pharmaceutical industry, specializing in sales, marketing, business development and pharmacovigilance. In 2008, he completed the Executive MBA program at the University of Quebec in Montreal. During his 13 years working for domestic and international companies, he gained expertise in various therapeutic areas. In 2010, he joined PBKM as Sales and Marketing Director. In 2012, he was appointed to the Management Board and has been Executive Vice President since 2020. Tomasz Baran has participated in international executive education programs and contributes to strategic projects of the Group. Tomasz Baran has been CCO of Vita 34 AG since 22 March 2022.